CeriBell, Inc.
CBLLNASDAQHealthcare● Active
$18.25
+$0.00(+0.03%)
Market Cap$692454275
P/E Ratio—
52W High$24.33
52W Low$10.85
CeriBell, Inc.（CBLL）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CBLL · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $89.06M | $65.44M | $45.23M | $25.92M |
| Cost of Revenue | $10.79M | $8.69M | $7.06M | $4.43M |
| Gross Profit | $78.27M | $56.75M | $38.16M | $21.49M |
| Gross Margin %(computed) | 87.89% | 86.72% | 84.38% | 82.91% |
| Operating Expenses | ||||
| R&D Expenses | $19.14M | $13.56M | $8.99M | $7.24M |
| G&A Expenses | $44.45M | $33.84M | $20.29M | $18.46M |
| Total Operating Expenses | $136.68M | $96.46M | $68.20M | $57.51M |
| Operating Income | ($58.40M) | ($39.71M) | ($30.04M) | ($36.02M) |
| Operating Margin %(computed) | -65.57% | -60.68% | -66.43% | -138.96% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $1.89M | $1.99M | $2.10M | $1.60M |
| Income Before Tax | ($53.41M) | ($40.45M) | ($29.45M) | ($37.16M) |
| Income Tax Expense | $0.00M | $0.00M | $0.01M | $0.00M |
| Net Income | ($53.41M) | ($40.45M) | ($29.46M) | ($37.16M) |
| Net Margin %(computed) | -59.97% | -61.82% | -65.15% | -143.37% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-1.46 | $-3.39 | $-1.26 | $-1.59 |
| Wtd Avg Shares | 36.54M | 11.95M | 23.32M | 23.32M |
| EBITDA | ($51.52M) | ($37.32M) | ($26.51M) | ($35.06M) |
| EBITDA Margin %(computed) | -57.85% | -57.03% | -58.61% | -135.26% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解CeriBell, Inc.
关于CeriBell, Inc.（CBLL）损益表
CeriBell, Inc.（CBLL）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CBLL实现营收$0.09B，毛利润$0.08B（毛利率87.89%），净利润($0.05B)（净利率-59.97%）。
常见问题
CBLL · 4 问CeriBell, Inc.（CBLL）2025财年营收为$0.09B，同比up36.1%。
CBLL revenueCBLL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08